What this record means
The record shows that “GABITRIL” is a live, registered mark on the Principal Register, owned by CEPHALON LLC, a Delaware limited liability company. It protects a pharmaceutical preparation for treating neurological disorders, the only goods listed. A similar name would raise the closest concern in the same pharmaceutical category, especially for neurological treatments. The record does not give the owner control over every use of the word “Gabitril” in unrelated contexts. The mark was registered on May 5 1998 and has been renewed, with the most recent renewal event noted on May 14 2018. No opposition, cancellation, or enforcement actions appear in the supplied history, so the record shows no visible enforcement activity. For anyone considering a similar name, the primary risk lies in the pharmaceutical field for neurological disorders, where this mark’s active status could create a meaningful concern.
Informational only - not legal advice.